Public Health Scotland (PHS) is proposing to close our annual publication on Medicines Used In Mental Health. This publication was first published in 2006 by Information Services Division Scotland.
PHS would like to hear from potential data users within health service provision, government, academia, third sector and the public in order to understand what data and analysis would be most useful and meaningful to those users. PHS would then relaunch this report with a much improved health intelligence offering set in the context of wider mental health service provision. This is in line with the UK Statistics Authority Code of Practice for Official Statistics (external website), which encourages user engagement to ensure that publications are of public value.
Note that the items, quantity and costs measures reported in the Medicines Used In Mental Health publication are readily available elsewhere in the Prescriptions In The Community Open Data release and Dispenser Payments and Prescription Cost Analysis publications. Patient numbers for a number of mental health medicines classes are reported on the COVID-19 Wider Effects dashboard.
PHS would like to hear the views from users regarding:
- the closure of this publication
- what affect this closure may have on them
- their views on the proposed improvement.
We have produced supporting information to:
- highlight the current situation for the Medicines Used In Mental Health annual report
- explain the reasons for consultation
- highlight the proposed process for improvement.
Take part in the consultation
This consultation period will be open from 1 November 2021 to 10 December 2021, with the new publication intended for release in late 2022 to early 2023.
For further information contact firstname.lastname@example.org